Dr Robbie Fyfe graduated from the University of Otago with a Bachelor of Medicine and Bachelor of Surgery in 2014. Since then he has worked as a house officer and medical registrar at Wellington Regional Hospital and Hutt Valley Hospital in numerous specialties including haematology.
Alongside his clinical work, he has presented on clinical research at the New Zealand Rheumatology Association conference and the New Zealand Society of Gastroenterology conference. He started work at the Malaghan Institute as a Clinical Research Fellow in 2021.
He is a co-investigator of the phase 1b ENABLE CAR T-cell clinical trial, and is a key part of the team delivering the treatment to patients. He is a current Master of Clinical Research student in addition to his research and clinical work.
"My research interests are focused on improving the treatment of haematological malignancies, such as lymphoma and myeloma. This involves finding treatment that are more effective, and the ability of chimeric antigen receptor (CAR) T-cells to harness a patient’s own immune system and focus it against a cancer is very promising. My hope for the future is finding more treatments that use the immune system to treat cancer, rather than using conventional chemotherapy.
"Improving the treatment of cancers also involves making treatments easier and more tolerable for patients, which is the focus of my Master's thesis. This includes making more treatments available in the outpatient setting, and improving the prevention and treatment of infections after immunotherapy such as CAR T-cells."